Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab.
Chia Jie TanRajneesh KumarNarendran KoomananWei Sheng LooMohamad FaridMiriam TaoNagavalli SomasundaramEileen PoonJason Yongsheng ChanValerie Shiwen YangEsther ChangSoon Thye LimWan Cheng ChowAlexandre ChanTiffany TangPublished in: Pharmacotherapy (2021)
The surveillance protocol is an effective, feasible and cost-saving strategy to manage HBV reactivation among lymphoma patients with resolved HBV infection receiving rituximab.